Anti-Human CD134/TNFRSF4/OX40 Reference Antibody (MSB013)

Description: Anti-Human CD134/TNFRSF4/OX40 (MSB013) (BS11790) is a research-grade recombinant antibody targeting CD134. Produced in mammalian cells with native-like glycosylation.
Highlights:
• Research Grade — For PK/PD studies, assay development, and ADA research.
• Native Glycosylation — Mammalian expression ensures native-like patterns.
Host species: Human
Isotype: IgG
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: ACT35antigen,TXGP1L,TAXtranscriptionally-activatedglycoprotein1receptor,Tumornecrosisfactorreceptorsuperfamilymember4,TNFRSF4,OX40Lreceptor,CD134
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: MSB013
Background: Tumor necrosis factor receptor superfamily member 4 (CD134/OX40) is a ~29 kDa protein. Receptor for TNFSF4/OX40L/GP34. Is a costimulatory molecule implicated in long-term T-cell immunity.
Note: For research use only. Not suitable for clinical or therapeutic use.